Banking Services: Cannabis Businesses Face Access Challenges

GAO found that roughly 1,000 U.S. banks and credit unions filed cannabis-related suspicious activity reports in 2024, with the number of reporting institutions broadly steady since 2019. Despite FinCEN's 2014 guidance, cannabis-related businesses continue to face account closures, elevated banking fees and loan rates, and payment-acceptance constraints, including prohibitions on cannabis purchases by two major card networks. Legal exposure under federal cannabis prohibition and Bank Secrecy Act compliance costs remain key deterrents for financial institutions serving the sector.

Analysis

The investable read-through is less about incremental demand and more about a persistent cost-of-capital wedge. U.S. multi-state operators (MSOS; GTBIF, TCNNF, CURLF) remain structurally disadvantaged versus federally legal consumer businesses because restricted deposit, lending, and card acceptance capacity raises cash handling, compliance, insurance, and working-capital costs. That burden favors scaled operators with established state footprints and internal cash generation, while smaller private dispensaries and cultivators face greater dilution or closure risk; over 6-18 months, this can support share gains and local wholesale-price discipline for the largest operators.

There is no evident near-term regulatory catalyst in this development, so a broad cannabis-sector rerating would be difficult to justify. The key 1-3 month risk is that investors interpret continued institutional participation as evidence that banking reform is unnecessary, reducing legislative urgency and compressing the reform-option premium embedded in MSOS. Conversely, any movement on SAFER Banking, DEA rescheduling implementation milestones, or explicit card-network policy changes would disproportionately benefit retail-heavy operators by lowering cash friction and potentially expanding transaction frequency, although card acceptance itself likely requires clearer federal legal protection.

Contrarian view: the market may over-focus on whether banks will serve the sector and underweight where the economics accrue. Specialty compliance providers and cannabis-focused lenders can preserve elevated yields while access remains constrained, whereas large diversified banks and Visa (V)/Mastercard (MA) have immaterial earnings sensitivity and substantial federal enforcement downside. The better structural expression is selective exposure to scale winners rather than a blanket long in cannabis equities, whose valuations remain dominated by tax treatment, state pricing, and federal-policy timing.

Key Decisions for Investors

• No immediate directional trade on this report alone; treat it as confirmation of an existing structural constraint rather than a new earnings catalyst. Avoid adding to MSOS solely on banking-access headlines until a legislative calendar, committee action, or agency implementation date is identifiable.
• Maintain a 6-18 month quality basket tilted to GTBIF and TCNNF versus smaller, externally financed U.S. operators; use MSOS as the liquid sector proxy only after federal reform probability rises. Thesis is falsified by sustained state-level price deflation, negative operating cash flow at the large operators, or a material delay/reversal in federal rescheduling.
• For a reform catalyst, consider a defined-risk call spread on MSOS with 6-12 months maturity rather than outright common exposure. Entry trigger: verifiable Senate floor scheduling or a final DEA rule; size for binary policy risk, with maximum premium loss accepted if reform again stalls.
• Do not express this through longs in V, MA, or major money-center banks: cannabis payment and deposit economics are too small to matter, while any change in network policy would be driven by legal clarity rather than this operational backdrop. Monitor payment-acceptance policy as an indicator for dispensary revenue conversion, not as a direct network earnings trade.